We are live on
!
Find out more
RCYC
Richard C. Young & Co Portfolio holdings
AUM
$1.36B
1-Year Est. Return
66.41%
This Fund
S&P 500
This Quarter
Est. Return
+5.83%
1 Year Est. Return
+66.41%
3 Year Est. Return
+137.43%
5 Year Est. Return
+151.84%
10 Year Est. Return
+342.18%
AUM
$600M
AUM Growth
+$44M
(+7.9%)
Cap. Flow
+$14.2M
Cap. Flow
% of AUM
2.36%
Top 10 Holdings %
Top 10 Hldgs %
30.35%
Holding
73
New
4
Increased
55
Reduced
7
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alerian MLP ETF
AMLP
|
+$7.59M |
| 2 |
SPDR Gold MiniShares Trust
GLDM
|
+$4.22M |
| 3 |
Pfizer
PFE
|
+$3.85M |
| 4 |
ExxonMobil
XOM
|
+$1.48M |
| 5 |
Fidelity MSCI Energy Index ETF
FENY
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AMJ
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
|
+$6.18M |
| 2 |
iShares US Pharmaceuticals ETF
IHE
|
+$3.82M |
| 3 |
SPDR Gold Trust
GLD
|
+$3.59M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$1.99M |
| 5 |
HEP
Holly Energy Partners, L.P.
HEP
|
+$1.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.28% |
| 2 | Financials | 12.79% |
| 3 | Consumer Staples | 11.95% |
| 4 | Technology | 8.75% |
| 5 | Industrials | 8.72% |
Similar funds
ACM
SEP
TA
MC
WTB
VC
LWM
SFM
Richard C. Young & Co's Q4 2019 Portfolio in Review
As of Q4 2019, Richard C. Young & Co held 73 positions worth $600M, up 7.9% from $556M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Richard C. Young & Co's Q4 2019 filing shows 4 new, 55 increased, 7 reduced and 5 closed positions. Its largest new stake was Fidelity MSCI Energy Index ETF: 68,046 shares worth $1.09M. The largest sale was JP Morgan Alerian MLP Index ETN 5/24/24, an estimated $6.18M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Staples.
- Richard C. Young & Co's largest Q4 2019 buy was Fidelity MSCI Energy Index ETF: 68,046 shares worth $1.09M.
- Richard C. Young & Co added most to Alerian MLP ETF in Q4 2019, an estimated $7.59M increase.
- Richard C. Young & Co's biggest Q4 2019 reduction was JP Morgan Alerian MLP Index ETN 5/24/24, cutting an estimated $6.18M.
- Richard C. Young & Co fully exited iShares US Pharmaceuticals ETF in Q4 2019, selling an estimated $3.82M.
- Richard C. Young & Co's ten largest holdings make up 30% of its $600M portfolio in Q4 2019.
- Richard C. Young & Co opened 4 new positions and closed 5 in Q4 2019.
- Richard C. Young & Co's portfolio value rose 7.9% quarter-over-quarter to $600M.
Based on Richard C. Young & Co's 13F filing for Q4 2019, filed 12 Feb 2020.